Enclomiphene citrate regulatory update

FDA’s Bone, Reproductive and Urologic Products Advisory Committee will meet on Nov. 3 to discuss an NDA from Repros for enclomiphene to treat secondary hypogonadism in overweight men. The PDUFA date i...